Navigation Links
Baxa Corporation Announces 2011 Course Schedule for its STAR Center® Training Facility
Date:10/26/2010

ENGLEWOOD, Colo., Oct. 26 /PRNewswire/ -- Baxa Corporation, a leading provider of medical devices and systems that automate pharmacy operations, today announced the 2011 dates for its STAR (Skills Training, Academics and Resources) Center.  Located at the Baxa global headquarters in Englewood CO, the STAR Center furthers best practice in health-system pharmacy operations.  The ACPE-accredited 2011 curriculum offers participants hands-on training in a state-of-the-art cleanroom and pharmacy training facility.

2011 marks the third consecutive year that Baxa has partnered with USP to provide training in aseptic compounding activities at the STAR Center facility.  Professionals in the USP Council of Experts, Sterile Compounding Committee and other industry-leading faculty participate as instructors for the Aseptic Processing and Compliance Tools for USP 797 course.  

The STAR Center will offer the following courses in 2011:  

Aseptic Processing and Compliance Tools for USP 797

This two-and-a-half day training program benefiting pharmacy and IV managers covers facility and environmental requirements for compounding sterile products in compliance with USP 797.  Upon completion of the program, participants earn 21 hours of CE credits including one hour of law credit or 2.1 Continuing Education Units (CEUs).  The cost of attendance is $1,875 and the course will be offered three times: March 8-10; May 17-19; and Sept. 20-22, 2011.

Safe Handling and Preparation of Cytotoxic and Other Hazardous Drugs

Designed to educate pharmacists, technicians, nurses, nurse managers and physicians regarding best practices of safely preparing and handling hazardous drugs, this ten-hour course will be held three times in 2011.  Topics covered include engineering controls required for compounding hazardous drugs, proper use of closed-system drug transfer devices (CSDTDs), procedures for handling hazardous drug spills, hazardous waste containment and disposal, and regulatory compliance.  This program is approved for continuing education credits.  Visit the course page for specifics by attendee classification.  The cost of attendance is $995 and the course will be offered March 11; May 20; and Sept. 23, 2011.

Visit the STAR Center website to register or request additional information on the 2011 course schedule.

About the STAR CenterThe STAR Center is a state-of-the-art cleanroom, pharmacy and training facility located at the Baxa world headquarters in Englewood, Colorado.  The center was purpose-built to support training in aseptic technique, pharmacy workflow and practice, cleanroom design and maintenance and USP 797 compliance among other topics.  Classes are taught by industry-recognized subject matter experts.  Further information is available at http://starcenter.baxa.com/.

About USPThe United States Pharmacopeia (USP) is a scientific, nonprofit, standards-setting organization that advances public health through public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods.  USP's standards are recognized and used worldwide.  For more information about USP visit http://www.usp.org.

About Baxa CorporationBaxa, a customer-focused medical device company, provides innovative, solution-based technologies for medication handling and delivery.  Its systems and devices promote the safe and efficient preparation, handling, packaging, and administration of medications.  Key products include the Abacus® Order Entry and Calculation Software, the DoseEdge™ Pharmacy Workflow Manager, ExactaMed® Oral Syringes, ExactaMix™ Automated Compounding Devices, InFuse™ and MicroFuse® Syringe Infusers, Repeater™ Pharmacy Pumps, NeoThrive® Enteral Syringes, the PadLock®  Set Saver and the RapidFill™ and IntelliFill® i.v. Automated Syringe Fillers; used worldwide in hospitals and healthcare facilities.  Privately held, Baxa Corporation has subsidiaries and sales offices in Florida, Canada and the United Kingdom; direct representation in Austria, Belgium, Denmark, Finland, France, Germany, Italy, Luxembourg, The Netherlands and Switzerland; and distribution partners worldwide.  Further information is available at www.baxa.com.Contact:Perrin McCormick or Brandie GerrishHB | Hart-Boillot: 781-893-0053Email: baxa@hartboillot.com
'/>"/>

SOURCE Baxa Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. United American Healthcare Corporation Names John M. Fife as Chairman of the Board
2. Cephalon Exercises its Option to Acquire BioAssets Development Corporation
3. CVS Caremark Corporation to Hold Third Quarter 2010 Conference Call
4. Luminex Corporation Third Quarter Earnings Release Scheduled for November 4, 2010
5. Cardiogenesis Corporation to Report 2010 Third Quarter Results on November 3rd
6. Physicians Pharmaceutical Corporation Offers Innovative On-Site Drug Dispensaries
7. Luminex Corporation Hosts Eighth Annual Planet xMAP Europe in Vienna
8. Tecan Group and Luminex Corporation Partner to Develop Automated Newborn Screening Solution
9. Arable Corporation Announces New Technology for Clinical Trial Industry
10. Kensey Nash Corporation Announces Its First Quarter Fiscal Year 2011 Earnings Release Date and Teleconference
11. Medical Simulation Corporation Signs Agreement With a Nationally Ranked Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... BOSTON , March 27, 2017 ... pharmaceutical company and Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), ... commercialization of innovative therapies based upon tetracycline chemistry, ... sarecycline for the treatment of moderate to severe ... Sarecycline is a once-daily, oral, narrow spectrum tetracycline-derived ...
(Date:3/27/2017)... 2017  Impax Laboratories, Inc. (NASDAQ: IPXL)today announced that ... Bisaro as Impax,s President and Chief Executive Officer ... 27, 2017. Mr. Bisaro will succeed J. Kevin ... Chief Executive Officer since December of 2016. ... experience, Mr. Bisaro, 56, is an accomplished global business ...
(Date:3/27/2017)... March 27, 2017  PhaseRx, Inc. (NASDAQ: PZRX), ... inherited liver diseases in children, today reported financial ... ended December 31, 2016 and provided an update ... continued to make progress during the fourth quarter ... from our non-human primate safety study, and with our ...
Breaking Medicine Technology:
(Date:3/27/2017)... ... ... still in shock after receiving a $2,500 Academic Award from California Casualty . “This ... She thinks the coming week is going to be a very joyful for her classroom. ... students.” , The award will allow the 4th grade teacher at Tumwater Hill Elementary School ...
(Date:3/27/2017)... ... March 27, 2017 , ... ?Grow Healthy ... resolve the pending litigation between itself and 1800 Vending DBA Healthy You Vending. ... “I am thrilled to announce that we have now reached a settlement agreement ...
(Date:3/26/2017)... (PRWEB) , ... March 26, 2017 , ... ... worldwide to receive the RealSelf 100 Award, a prestigious award honoring the top ... procedures and to find and connect with doctors and clinics. , In 2016, ...
(Date:3/24/2017)... York, NY (PRWEB) , ... March 24, 2017 ... ... campaign: “Fighting Infection,” which will spark a conversation on the current obstacles facing ... the number of completely preventable deaths caused by these infections. , The ...
(Date:3/24/2017)... ... March 24, 2017 , ... Texas Physical Therapy Specialists (TexPTS) is ... 9618 Huebner Road. The clinic is the group’s 7th location in San Antonio and ... Higgins, PT, will provide care from the clinic, which opened March 22, 2017. ...
Breaking Medicine News(10 mins):